Spenopalatine Ganglion Blocks: A Powerful Tool in The Battle Against Headaches and Migraines

The SPG Block or Spenopalatine Ganglion block is one of the most potent weapons for the treatment and prevention of Headaches, Migraines  and othe Trigeminally induced headaches.

The Spenopalatine Ganglion (pterygopalatine ganglion) is the largest parasympathetic ganglia in the head.

Dr Shapira teaches courses to physicians and dentists no techniques of delivering Sphenopalatine Ganglion Blocks.

Visit  www.spenopalatineGanglionBlocks.com to learn more or see amazing patient testimonials on YouTube.

https://www.youtube.com/channel/UCk9Bfz6pklC7_UluWFHzLrg

SPG Block: Miracle Cure of Prevention for Migraines. Courses in SPG Block Administration by Dr Ira Shapira

SPG Block are often considered Miracle Treatments for Migraines and other chronic pains. The Book “Miracles on Park Avenue” was published in the late 1980’s and Dr Shapira learned the technique shortly after by his friend Dr Jack Haden. Dr Shapira later learned several other methods of utilizing the SPG Block from Dr Larry Lockerman, Dr Barry Glassman, Dr Lawrence Robbins, Dr Brendan Stack. He also trained with TX360 and Spenocath techniques.

Dr Shapira is one of very few doctors around the world who teaches patients to self administer Sphennopalatine Ganglion Blocks. He is currently working on Patents which will vastly improve the range of treatments that can be directed toward this autonomic ganglion.

The following was originally published at NorthShoreSleepDentist.com

PATIENTS WHO ARE INTERESTED IN EXPERIENCING SPHENOPALATINE GANGLION BLOCKS AND LEARNING HOW TO SELF ADMINISTER THE BLOCKS CAN CONTACT DR SHAPIRA THRU HIS WEBSITE.
WWW.THINKBETTERLIFE.COM

TREATMENT OF CHRONIC MIGRAINES, TENSION HEADACHES AND AUTONOMIC CEPHALGIAS AS WELL AS OTHER CHRONIC PAIN CONDITIONS CAN BE IMPROVED WITH UTILIZATION OF SPHENOPALATINE GANGLION BLOCKS.

There are several testimonials on SPG Blocks at ICCMO:
http://occlusiontmjauthority.com/dr-ira-shapira-testimonials/

WHERE DO YOU LEARN TO ADMINISTER SPG BLOCKS? Dr Shapira now offers classes in Highland Park!

It is well established that the Sphenopalatine Ganglion Block is one of the most effective treatments for preventing migraine and chronic daily headaches available but it is often difficult to learn the procedures. I teach Sphenopalatine Ganglion Administration in my Highland Park, Illinois office to doctors want to incorporate this into their practice and to patients wanting to learn self administration of SPG Blocks.

I teach a variety of trigger point injection techniques in the jaw, head, neck and shoulder regions to both dentists and physicians. I invite doctors to bring their patients with them to the course. The primary area of interest of many doctors is learning to do the Sphenopalatine Ganglion Blocks. I teach doctors several methods of administering SPG Blocks. Doctors are invited to bring their team and their patients to the course as well.

The Sphenopalatine Ganglion Block was made popular in the late 1980’s by the book “Miracles on Park Avenue”. I strongly suggest that patients with chronic pain, migraines, tension headaches or TMJ Disorders read this book.

The Spenopalatine Ganglion, also called Meckels Ganglion, the Nasal Ganglion or the Pterygopalatine Ganglion is the largest of four Parasympathetic Ganglions in the head and neck and has both sympathetic and parasympathetic fibers running throught it. It is found in the Pterygopalatine fosa. The SPG is associated with the branches of the maxillary nerve,one of the three major branches of the Trigeminal Nerve.

The SPG supplies the lacrimal gland, paranasal sinuses, glands of the mucosa of the nasal cavity and pharynx, the gingiva, and the mucous membrane and glands of the hard palate. It communicates anteriorly with the nasopalatine nerve, also part of the Trigeminal Nerve. The SPG receives a sensory, a parasympathetic, and a sympathetic root.
The sensory root of the Sphenopalatine Ganglion comes from two sphenopalatine branches of the maxillary division of the Trigeminal Nerve and the fibers pass into the palatine nerves.

The Parasympathetic root is derived from the nervus intermedius a branch of the facial nerve.
The SphenoPalatine Ganglion also carries fibers from the superior cervical ganglion, SCG. These are sympathetic efferent (postganglionic) fibers from the SCG that travel through the carotid plexus and then through the deep petrosal nerve, which joins with the greater petsal nerve to form the pterygoid canal nerve.

Learnig to work with SphenoPalatine Ganglion blocks will allow practitiones to handle difficult cases that were often resistant to treatment because of their autonomic components. All classes are by by appointment. I will teach individual doctors or small groups.

SPG Nerve Block catheter Bibliography
CHRONIC DAILY HEADACHE AND MIGRAINE
Agency of Healthcare Research and Quality, a division of the Department of Health &
Human Services, “Over 3 Million Look to Hospitals for Headache Relief,
Particularly for Migraines,” http://www.ahrq.gov/news/nn/nn050411.htm
Archibald N, et al. Resource Utilization and Costs of Care for Treatment of Chronic
Headache. Rockville (MD): Agency for Health Care Policy and Research (US);
February 1999, http://www.ncbi.nlm.nih.gov/books/NBK45258/
Castillo, J, et al. Epidemiology of Chronic Daily Head in the General Population,
Headache, March 1999, http://www.ncbi.nlm.nih.gov/pubmed/15613213
CIA World Fact Book, https://www.cia.gov/library/publications/the-worldfactbook/
fields/2002.html
Coeytaux, RR, et al. Chronic daily headache in a primary care population: prevalence
and headache impact test scores. Headache. 2007 Jan; 47(1): 7-12,
http://www.ncbi.nlm.nih.gov/pubmed/17355488
Cohen, S, et al. A new interest in an old remedy for headache and backache for our
obstetric patients: a sphenopalatine ganglion block. Anaesthesia, 2000, 56, 606-
07, http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2044.2001.2094-34.x/full
Evans, RW, Diagnostic Testing for Chronic Daily Headache, Current Pain and
Headache Reports 2007, 11:47-52,
http://www.rwevansmd.com/EvansPublictations/Diagnostic%20testing%20for%2
0chronic%20daily%20headache.pdf
Garza, I, et al. Diagnosis and Management of Chronic Daily Headache. Semin Neurol
2010; 30(2): 154-166, http://www.medscape.com/viewarticle/723842
Halker, RB, et al. Chronic Daily Headache: An Evidence-Based and Systemic
Approach
to a Challenging Problem. Neurology Clinical Practice 2011:76 (Suppl 2): S37-
S43, http://www.neurology.org/content/76/7_Supplement_2/S37.full.pdf
Hu, XH, et al. Burden of Migraine in the United States. Arch Intern Med. Vol. 159,
Apr. 26, 1999, http://archinte.ama-assn.org/cgi/content/abstract/159/8/813
In office surgical fee schedule at
http://dir.alabama.gov/wc/FeeSchedules/2009_In_Office_Surgery_Fee(Effective_
7-15-09).pdf
Lafata, JE, et al. The medical Care Utilization and Costs Associated with Migraine
Headache. J Gen Intern Med. 2004 October; 19(10): 1005-1012,
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1492574/
Lucado, J, et al. Headaches in U.S. Hospitals and Emergency Departments, 2008.
Statistical Brief #111, published May 2011, Healthcare Cost and Utilization
Project, http://www.hcup-us.ahrq.gov/reports/statbriefs/sb111.pdf.
Machlin, S., and Chowdhury, S., “Expenses and Characteristics of Physician Visits in
Different Ambulatory Care Settings, 2008.” Statistical Brief #318. March 2011.
Agency for Healthcare Research and Quality, Rockville, MD,
http://www.meps.ahrq.gov/mepsweb/data_files/publications/st318/stat318.pdf
Munakata, J, et al. Economic burden of transformed migraine: results from the
American
Migraine Prevalence and Prevention (AMPP) Study. Headache 2009 Apr; 49(4):
498-508, http://sibelium.com.cn/sibelium/WX/fulltext_WX_8/06.pdf
Natoli, JL, et al. Global Prevalence of Chronic Migraine: A Systematic Review.
Cephalalgia, May 2009,
http://www.sibelium.com.cn/sibelium/WX/fulltext_WX_13/07.pdf
Ramirez-Lassepas M, et al. Predictors of intracranial pathologic findings in patients
who seek emergency care because of headache. Arch Neurol. 1997 Dec; 54(12):
1506-9, http://www.ncbi.nlm.nih.gov/pubmed/9400360
Silberstein, SD, et al. “Chronic Daily Headache,” 2012, at
http://www.neurotoxininstitute.com/index.php?option=com_content&view=articl
e&id=144&Itemid=89
Silberstein, SD. Chronic Daily Headache: Classification, Epidemiology, And Risk
Factors. Johns Hopkins Advanced Studies in Medicine, October 2006,
http://www.jhasim.com/files/articlefiles/pdf/ASIM_6_9C_p885_890.pdf
TRIGEMINAL NERVE BLOCK
Cohen, S, et al. Sphenopalatine ganglion block for postdural puncture headache.
Anaesthesia, 2009, 64, 574.
Dodick, DW. Chronic Daily Headache. N Engl J Med 12 Jan. 2006; 354:158-65,
http://www.nejm.org/doi/full/10.1056/NEJMcp042897
Harrison, Pam. Stellate Ganglion Blockade Shows Promise as Effective, Durable
Treatment for PTSD. http://www.medscape.com/viewarticle/721079
Peterson, JN, et al. Sphenopalatine ganglion block: a safe and easy method for the
management of orofacial pain. Cranio The Journal Of Craniomandibular
Practice. 1995, Volume: 13, Issue: 3, Pages: 177-181,
http://www.ncbi.nlm.nih.gov/pubmed/8949858
Quevedo, JP, et al. Complex Regional Pain Syndrome Involving the Lower Extremity:
A
Report of 2 cases of Sphenopalatine Block as a Treatment Option. Arch Phys
Med Rehabil. 2005 Feb; 86(2): 335-37,
http://www.ncbi.nlm.nih.gov/pubmed/15706564
Reder, M. “Conditions Treated with SGB,”
http://drmiltonreder.com/index.php/about/conditions-treated-with-sgb/
Saberski, L, et al. Sphenopalatine ganglion block for treatment of sinus arrest in
postherpetic neuralgia. Headache. 1999 Jan; 39(1): 42-4,
http://www.ncbi.nlm.nih.gov/pubmed/15613194
Sluder G. The role of the sphenopalatine ganglion in nasal headaches. N Y State J
Med
1908: 27: 8-13.
Washington State Hospital Association, “Washington State Hospital Association
Emergency Room Use,” review of 2,631,071 ED visits over an 18-month period
with 42,816 visits for headaches, http://www.wsha.org/files/127/ERreport.pdf
INTRANASAL
Kanai, A, et al. Intranasal lidocaine 8% spray for second-division trigeminal neuralgia.
Br J Anaesth. 2006 Oct; 97(4): 559-63,
http://bja.oxfordjournals.org/content/97/4/559
Kudrow L, et al. Rapid and sustained relief of migraine attacks with intranasal
lidocaine:
preliminary findings. Headache. 1995 Feb; 35(2): 79-82,
http://www.ncbi.nlm.nih.gov/pubmed/7737865
Maizels, M, et al. Intranasal Lidocaine for Treatment of Migraine: A Randomized,
Double-blind, Controlled Trial. JAMA, July 24/31, 1996—Vol. 276, No. 4,
http://jama.ama-assn.org/content/276/4/319.short
Rosen, N. Effect of Lidocaine Infusion in the Treatment of Refractory Chronic Daily
Headache – A Retrospective Study. Poster P04.099. Reported by Jill Stein at
http://www.docguide.com/intravenous-lidocaine-has-role-refractory-chronicheadachepresented-aan

Williams, D, et al. Intravenous lignocaine (lidocaine) infusion for the treatment of
chronic daily headache with substantial medication overuse. Cephalalgia, 23
(December 2003): 963-971, http://www.ncbi.nlm.nih.gov/pubmed/14984229
World Health Organization (WHO) website,
http://www.who.int/mediacentre/factsheets/fs277/en/

#SPB, #SPGBLOCK, #SPHENOPALATINEGANGLIONBLOCK, #meckel’sganglion, #pterygopalatineganglion, #autonomicblocks, #parasympathetic , #parasympatheticblocks, #adrenylsyndrome, #SPGBlockMigraine, #SPGBlockChronicDailyHeadache, #WheretolearnSPGBlocks, #WhodoesSPGBlocks ##Wheretolearnsphenopalatineganglionblocks,

Myofascial Pain Syndrome: MPS. A New Nomenclature for Myofascial Pain and Dysfunction: MPD

Myofascial Pain Syndrome: MPS

Relief of chronic Myofascial Pain and Dysfunction at www.ThinkBetterLife.com

Myofascial Pain Syndrome is a ewer term than Myofascial Pain and Dysfunction. It specifically takes Dysfunction out of the disorder which is a major mistake. Myofascial Pain is a disuse / misuse syndrome and is always a type of repetitive strain disorder.

TMJ Disorders, TMD,, Craniofacial Pain, Tension Headaches, Migraines,Cervicalgia and almost all chronic head and neck pain is directly related to Myofascial Pain and Dysfunction, MPD, MPS, Myofascial Pain Syndrome.  

Amazing Videos of Pain Relief from Migraines, TMJ, TMD, MPD, MPS, Fibromyalgia, Myofascial Pain Syndrome and Myofacial Pain and Dydfunction.

https://www.youtube.com/channel/UCk9Bfz6pklC7_UluWFHzLrg

Visit Dr Shapira's website to learn more and schedule an appointment.
www.ThinkBetterLife.com

 This type of change is designed to allow drug therapy instead of addressing underlying issues. It is part of an unfortunate swing in medicine to avoid cause and effect, corrrective actions, physical therapy, exercise, manual therapy and instead look at treatment with pharmaceuticals

90-95% of all pain is Myofascial Pain or pain coming from muscles and fascia. Dr Janet Travell wrote the book Myofascial Pain and Dysfunction: A Trigger Point Manual.

This youtube video is of a Fibromyalgia patient condemned by medicine to a life of constant pain. This diagnosis is faulty to say the least.
https://www.youtube.com/watch?v=A5xUFtuZe_Y
This patient has "Recovered" from fibromyalgia or never had fibromyalgia or the definition and signs and symptoms of fibromyalgia are a faulty system of diagnosis leading to faulty treatment.

Myofascial pain results from injury and chronic misuse of muscles. Repetiitive strain injury is the primary cause of SPG. Dysfunction or improper function is an essential issue in understanding these problems.

Myofascial pain is often mispronounced as Myofacial pain.

Fibromyalgia is a questionable diagnosis. How chronic MPD and Fibromyalgia are related is hotly contested. MPD patients recover and Fibromyalgia patients do not. Fibromyalgia can best be treated as systemic MPD but treating with the medical model leads to the medication model. This is a model that says recovery is not possible. I suggest treating all patients with a goal of complete remission initially. Treatment designed to promote healthy physiology is always better than treatment with medication to cover up symptoms.

Myofascial pain and Dysfunction (MPD) is a common, painful disorder that is responsible for many, if not the majority of pain clinic visits. MPD can affect any skeletal muscles in the body. Skeletal muscle accounts for approximately 50% of body weight, and there are approximately 400 muscles in the body. MP is responsible for many cases of chronic musculoskeletal pain and the diagnosis is commonly missed.

Mayo Clinic says about MPD "Myofascial pain syndrome is a chronic pain disorder. In myofascial pain syndrome, pressure on sensitive points in your muscles (trigger points) causes pain in seemingly unrelated parts of your body. This is called referred pain from muscle trigger points.."

Mayo clinic's description is actually and over-simplification. It is a result of distorted function that leads to formation of taut bands within the muscles. These are mediated through muscle spindles. The trigger points are areas of low EMG located in the taut band capable of causing pain referral to distant sites.

The term "Myofascial pain syndrome" leaves out the idea of Dysfunction. It is easy to move to medical management of functional problems when the dysfunction is discounted. MPD Typically occurs after a muscle has been contracted repetitively in an awkward manner. This can be caused by repetitive motions used in jobs or hobbies or by stress-related muscle tension. Tere is an enormous difference between healthy and unhealthy repetitive motions.

While nearly everyone has experienced muscle tension pain, the discomfort associated with myofascial pain and dysfunction syndrome persists or worsens over time if underlying issues are not corrected.. Treatment options for myofascial pain syndrome include physical therapy and trigger point injections. Pain medications and relaxation techniques also can help.

When patients also have TMJ disorders function becomes paramount.

MP can cause local or referred pain, tightness, tenderness, popping and clicking, stiffness and limitation of movement, autonomic phenomena, local twitch response (LTR) in the affected muscle, and muscle weakness without atrophy. Trigger points (TrPs), which cause referred pain in characteristic areas for specific muscles, restricted range of motion (ROM), and a visible or palpable LTR to local stimulation, are classic signs of MP. Over 70% of TrPs correspond to acupuncture points used to treat pain.[1]

An active TrP is an area that refers pain to a remote area in a defined pattern when local stimulation is applied. Satellite TrPs appear in response to a primary, active TrP and usually disappear after the primary TrP has been inactivated. Latent TrPs cause stiffness and limitation of ROM but no pain. Frequently, they are found in asymptomatic individuals.

Although MP and fibromyalgia have some overlapping features, they are separate entities; fibromyalgia is a widespread pain problem, not a regional condition caused by specific TrPs.

#myofascialpainSyndrome, #MPS,#MPS/MyofascialPainSyndrome , #IllinoisMPS, #ChicagoMPS, ##northshoreMPS, #HighlandParkMPS,
#ChicagoMyofascialPainSyndrome, #Illinoismyofascialpainsyndrome, #Northshoremyofascialpainsyndrome, #MayoclinincMPS, #Rehabilitationinstitutemyofascialpainsyndrome, #Universityofchicagomyofascialpainsyndrome